Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2018

26.04.2018 | Stanford Multidisciplinary Seminars

Perianal Extramammary Paget’s Disease: More Than Meets the Eye

verfasst von: Jeff Choi, Allison Zemek, Gordon K. Lee, Cindy Kin

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Excerpt

A 75-year-old man was initially evaluated for a 1-year history of perianal pruritus that was refractory to multiple topical therapies. He had a sharply demarcated, erythematous and scaly rash involving the left perianal skin, originating from the left hemi-circumference of the anal verge and extending anteriorly, laterally and posteriorly to involve a 6 cm × 4 cm area of skin (Fig. 1). A punch biopsy of the lesion confirmed extramammary Paget’s disease (EMPD). Immunostaining of the biopsy was positive for cytokeratin (CK)7 and GATA3, weakly positive for cytokeratin 20, and negative for CDX2 and prostate-specific antigen (PSA), all consistent with likely primary EMPD. Patient’s past history was notable for coronary artery disease and prostate cancer, for which he had undergone prostatectomy. His recent serum PSA had been unremarkable at 0.02 ng/mL. PSA immunostaining of the punch biopsy was negative, as was urine cytology, excluding underlying urothelial intraepithelial neoplasia. Further evaluation to exclude an underlying malignancy included computed tomography (CT) of the abdomen and pelvis, which was unremarkable. Colonoscopy from several months prior to initial presentation was likewise negative.
Literatur
1.
Zurück zum Zitat Lam C, Funaro D. Extramammary Paget’s disease: summary of current knowledge. Dermatol Clin. 2010;28:807–826.CrossRef Lam C, Funaro D. Extramammary Paget’s disease: summary of current knowledge. Dermatol Clin. 2010;28:807–826.CrossRef
2.
Zurück zum Zitat Mengun B, Zheng-Qiang W, Tasleem MM. Extramammary Paget’s disease of the perianal region: a review of the literature emphasizing management. Dermatol Surg. 2013;39:69–75.CrossRef Mengun B, Zheng-Qiang W, Tasleem MM. Extramammary Paget’s disease of the perianal region: a review of the literature emphasizing management. Dermatol Surg. 2013;39:69–75.CrossRef
3.
Zurück zum Zitat Tanaka VD, Sanches JA, Toresan L, Niwa AB, Festa Neto C. Mammary and extramammary Paget’s disease: a study of 14 cases and the associated therapeutic difficulties. Clinics. 2009;64:599–606.CrossRef Tanaka VD, Sanches JA, Toresan L, Niwa AB, Festa Neto C. Mammary and extramammary Paget’s disease: a study of 14 cases and the associated therapeutic difficulties. Clinics. 2009;64:599–606.CrossRef
4.
Zurück zum Zitat Wang X, Yang W, Yang J. Extramammary Paget’s disease with the appearance of a nodule: a case report. BMC Cancer. 2010;10:405.CrossRef Wang X, Yang W, Yang J. Extramammary Paget’s disease with the appearance of a nodule: a case report. BMC Cancer. 2010;10:405.CrossRef
5.
Zurück zum Zitat Perrotto J, Abbott JJ, Ceilley RI, Ahmed I. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease. Am J Dermatopathol. 2010;32:137.CrossRef Perrotto J, Abbott JJ, Ceilley RI, Ahmed I. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease. Am J Dermatopathol. 2010;32:137.CrossRef
6.
Zurück zum Zitat Chanda JJ. Extramammary Paget’s disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol. 1985;13:1009–1014.CrossRef Chanda JJ. Extramammary Paget’s disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol. 1985;13:1009–1014.CrossRef
7.
Zurück zum Zitat Zhu Y, Ye DW, Yao XD, et al. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget’s disease. Br J Dermatol. 2009;161:577–582.CrossRef Zhu Y, Ye DW, Yao XD, et al. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget’s disease. Br J Dermatol. 2009;161:577–582.CrossRef
8.
Zurück zum Zitat Tsutsumida A, Yamamoto Y, Minakawa H, et al. Indications for lymph node dissection in the treatment of extramammary Paget’s disease. Dermatol Surg. 2003;29:21–24.PubMed Tsutsumida A, Yamamoto Y, Minakawa H, et al. Indications for lymph node dissection in the treatment of extramammary Paget’s disease. Dermatol Surg. 2003;29:21–24.PubMed
9.
Zurück zum Zitat Nakamura Y, Fujisawa Y, Ishikawa M, et al. Usefulness of sentinel lymph node biopsy for extramammary Paget disease. Br J Dermatol. 2012;167:954–956.CrossRef Nakamura Y, Fujisawa Y, Ishikawa M, et al. Usefulness of sentinel lymph node biopsy for extramammary Paget disease. Br J Dermatol. 2012;167:954–956.CrossRef
10.
Zurück zum Zitat Fujisawa Y, Yoshino K, Kiyohara Y, et al. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget’s disease: multi-center, retrospective study of 151 patients. J Dermatol Sci.. 2015;79:38–42.CrossRef Fujisawa Y, Yoshino K, Kiyohara Y, et al. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget’s disease: multi-center, retrospective study of 151 patients. J Dermatol Sci.. 2015;79:38–42.CrossRef
12.
Zurück zum Zitat Ito Y, Igawa S, Ohishi Y, et al. Prognostic indicators in 35 patients with extramammary Paget’s disease. Dermatol Surg. 2012;38:1938–1944.CrossRef Ito Y, Igawa S, Ohishi Y, et al. Prognostic indicators in 35 patients with extramammary Paget’s disease. Dermatol Surg. 2012;38:1938–1944.CrossRef
13.
Zurück zum Zitat Hatta N, Yamada M, Hirano T, et al. Extramammary Paget’s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol. 2008;158:313–318.PubMed Hatta N, Yamada M, Hirano T, et al. Extramammary Paget’s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol. 2008;158:313–318.PubMed
14.
Zurück zum Zitat Karam A, Dorigo O. Treatment outcomes in a large cohort of patients with invasive extramammary Paget’s disease. Gynecol Oncol. 2012;125:346–351.CrossRef Karam A, Dorigo O. Treatment outcomes in a large cohort of patients with invasive extramammary Paget’s disease. Gynecol Oncol. 2012;125:346–351.CrossRef
15.
Zurück zum Zitat Aoyagi S, Akiyama M, Shimizu H. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget’s disease. J Dermatol Sci. 2008;50:177–184.CrossRef Aoyagi S, Akiyama M, Shimizu H. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget’s disease. J Dermatol Sci. 2008;50:177–184.CrossRef
16.
Zurück zum Zitat Hatta N, Morita R, Yamada M, et al. Sentinel lymph node biopsy in patients with extramammary Paget’s disease. Dermatol Surg. 2004;30:1329–1334.PubMed Hatta N, Morita R, Yamada M, et al. Sentinel lymph node biopsy in patients with extramammary Paget’s disease. Dermatol Surg. 2004;30:1329–1334.PubMed
17.
Zurück zum Zitat Hata H, Abe R, Hoshina D, et al. MUC5AC expression correlates with invasiveness and progression of extramammary Paget’s disease. J Eur Acad Dermatol Venereol. 2014;28:727–732.CrossRef Hata H, Abe R, Hoshina D, et al. MUC5AC expression correlates with invasiveness and progression of extramammary Paget’s disease. J Eur Acad Dermatol Venereol. 2014;28:727–732.CrossRef
18.
Zurück zum Zitat Lam C, Funaro D. Extramammary Paget’s disease: summary of current knowledge. Dermatol Clin. 2010;28:807–826.CrossRef Lam C, Funaro D. Extramammary Paget’s disease: summary of current knowledge. Dermatol Clin. 2010;28:807–826.CrossRef
19.
Zurück zum Zitat Perez DR, Trakarnsanga A, Shia J, et al. Management and outcome of perianal Paget’s disease. Dise Colon Rectum. 2014;57:747–751.CrossRef Perez DR, Trakarnsanga A, Shia J, et al. Management and outcome of perianal Paget’s disease. Dise Colon Rectum. 2014;57:747–751.CrossRef
20.
Zurück zum Zitat Minicozzi A, Borzellino G, Momo R, Steccanella F, et al. Perianal Paget’s disease: presentation of six cases and literature review. Int J Colorectal Dis. 2010;25:1–7.CrossRef Minicozzi A, Borzellino G, Momo R, Steccanella F, et al. Perianal Paget’s disease: presentation of six cases and literature review. Int J Colorectal Dis. 2010;25:1–7.CrossRef
21.
Zurück zum Zitat Hendi A, Brodland DG, Zitelli JA. Extramammary Paget disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2004;51:767–773.CrossRef Hendi A, Brodland DG, Zitelli JA. Extramammary Paget disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2004;51:767–773.CrossRef
22.
Zurück zum Zitat Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC, Milsom JW. Long-term outcome of patients with perianal Paget’s disease. Ann Surg Oncol. 1997;4:475–480.CrossRef Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC, Milsom JW. Long-term outcome of patients with perianal Paget’s disease. Ann Surg Oncol. 1997;4:475–480.CrossRef
23.
Zurück zum Zitat Hendi A, Brodland DG, Zitelli JA. Extramammary Paget’s disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2004;51:767–773.CrossRef Hendi A, Brodland DG, Zitelli JA. Extramammary Paget’s disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2004;51:767–773.CrossRef
24.
Zurück zum Zitat Housel JP, Izikson L, Zeitouni NC. Noninvasive extramammary Paget’s disease treated with photodynamic therapy: case series from the Roswell park cancer institute. Dermatol Surg. 2010;36:1718–1724.CrossRef Housel JP, Izikson L, Zeitouni NC. Noninvasive extramammary Paget’s disease treated with photodynamic therapy: case series from the Roswell park cancer institute. Dermatol Surg. 2010;36:1718–1724.CrossRef
25.
Zurück zum Zitat Shieh S, Dee AS, Cheney RT, Frawley NP, et al. Photodynamic therapy for the treatment of extramammary Paget’s disease. Br J Dermatol. 2002;146:1000–1005.CrossRef Shieh S, Dee AS, Cheney RT, Frawley NP, et al. Photodynamic therapy for the treatment of extramammary Paget’s disease. Br J Dermatol. 2002;146:1000–1005.CrossRef
26.
Zurück zum Zitat Vereecken P, Awada A, Ghanem G, Marques da Costa C, et al. A therapeutic approach to perianal extramammary Paget’s disease: topical imiquimod can be useful to prevent or defer surgery. Med Sci Monit. 2007;13:75–77. Vereecken P, Awada A, Ghanem G, Marques da Costa C, et al. A therapeutic approach to perianal extramammary Paget’s disease: topical imiquimod can be useful to prevent or defer surgery. Med Sci Monit. 2007;13:75–77.
27.
Zurück zum Zitat Zampognoa JC, Flowers FP, Roth WI, Hassenein AM. Treatment of primary limited cutaneous extramammary Paget’s disease with topical imiquimod monotherapy: two case reports. J Am Acad Dermatol. 2004;4:229–235. Zampognoa JC, Flowers FP, Roth WI, Hassenein AM. Treatment of primary limited cutaneous extramammary Paget’s disease with topical imiquimod monotherapy: two case reports. J Am Acad Dermatol. 2004;4:229–235.
28.
Zurück zum Zitat Hata M, Omura M, Koike I, Wada H, et al. Role of radiotherapy as curative treatment of extramammary Paget’s disease. Int J Radiat Oncol Biol Phys. 2011;80:47–54.CrossRef Hata M, Omura M, Koike I, Wada H, et al. Role of radiotherapy as curative treatment of extramammary Paget’s disease. Int J Radiat Oncol Biol Phys. 2011;80:47–54.CrossRef
29.
Zurück zum Zitat Dilmé-Carreras E, Iglesias-Sancho M, Márquez-Balbás G, Sola-Ortigosa J, Umbert-Millet P, et al. Radiotherapy for extramammary Paget disease of the anogenital region. J Am Acad Dermatol. 2011;65:192–194.CrossRef Dilmé-Carreras E, Iglesias-Sancho M, Márquez-Balbás G, Sola-Ortigosa J, Umbert-Millet P, et al. Radiotherapy for extramammary Paget disease of the anogenital region. J Am Acad Dermatol. 2011;65:192–194.CrossRef
30.
Zurück zum Zitat Yanagi T, Kato N, Yamane N, Osawa R, et al. Radiotherapy for extramammary Paget’s disease: histopathological findings after radiotherapy. Clin Exp Dermatol. 2007;32:506–508.CrossRef Yanagi T, Kato N, Yamane N, Osawa R, et al. Radiotherapy for extramammary Paget’s disease: histopathological findings after radiotherapy. Clin Exp Dermatol. 2007;32:506–508.CrossRef
31.
Zurück zum Zitat Kariya K, Tsuji T, Schwartz RA. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget’s disease. Dermatol Surg. 2004;30:341–344.PubMed Kariya K, Tsuji T, Schwartz RA. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget’s disease. Dermatol Surg. 2004;30:341–344.PubMed
32.
Zurück zum Zitat Matsushita S, Yonekura K, Mera K, Kawai K, Kanekura T. Successful treatment of metastatic extramammary Paget’s disease with S-1 and docetaxel combination chemotherapy. J Dermatol. 2011;38:996–998.CrossRef Matsushita S, Yonekura K, Mera K, Kawai K, Kanekura T. Successful treatment of metastatic extramammary Paget’s disease with S-1 and docetaxel combination chemotherapy. J Dermatol. 2011;38:996–998.CrossRef
33.
Zurück zum Zitat Takahagi S, Noda H, Kamegashira A, Madokoro N, et al. Metastatic extramammary Paget’s disease treated with paclitaxel and trastuzumab combination chemotherapy. J Dermatol. 2009;36:457–461.CrossRef Takahagi S, Noda H, Kamegashira A, Madokoro N, et al. Metastatic extramammary Paget’s disease treated with paclitaxel and trastuzumab combination chemotherapy. J Dermatol. 2009;36:457–461.CrossRef
Metadaten
Titel
Perianal Extramammary Paget’s Disease: More Than Meets the Eye
verfasst von
Jeff Choi
Allison Zemek
Gordon K. Lee
Cindy Kin
Publikationsdatum
26.04.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5089-1

Weitere Artikel der Ausgabe 11/2018

Digestive Diseases and Sciences 11/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.